---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-013372"
form_type: "8-K"
ticker: "BNKK"
cik: "0001760903"
company_name: "BONK, INC."
filed_at: "2025-06-03T23:59:59+00:00"
generated_at: "2026-05-20T01:48:57.752320+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Safety Shot expands R&D into nootropics and sleep aids leveraging Sure Shot technology

## Summary
- Company initiating R&D for nootropic and sleep aid product lines, leveraging Sure Shot technology.
- Sure Shot lowers blood alcohol content and boosts clarity, energy, and mood.
- Global nootropics market ~$6.5B, projected >$14.9B by 2034 (CAGR 8.7%).
- Sleep supplement market $6.8B (2023), projected $11.8B by 2034 (CAGR 5.1%).
- Prototypes expected later this year; product release in coming months.

## SEC filing metadata
- accession: 0001641172-25-013372
- form_type: 8-K
- ticker: BNKK
- cik: 0001760903
- company_name: BONK, INC.
- filed_at: 2025-06-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1760903/000164117225013372/0001641172-25-013372-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1760903/000164117225013372/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-013372
- JSON: https://secwatch.observer/filing/0001641172-25-013372.json
- Plain text: https://secwatch.observer/filing/0001641172-25-013372.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.